Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
47.95M | 48.12M | 49.91M | 52.17M | 53.48M | 51.22M | Gross Profit |
30.70M | 30.95M | 29.33M | 31.71M | 31.78M | 30.33M | EBIT |
-5.00M | -4.45M | -9.64M | -8.07M | -11.65M | -25.45M | EBITDA |
-3.20M | -1.80M | -5.76M | -4.03M | 2.22M | -36.18M | Net Income Common Stockholders |
-5.48M | -4.95M | -9.91M | -8.24M | -4.39M | -42.99M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.02M | 12.77M | 14.61M | 20.47M | 27.09M | 33.85M | Total Assets |
40.63M | 43.20M | 47.48M | 56.79M | 65.83M | 77.73M | Total Debt |
1.10M | 1.22M | 2.10M | 1.64M | 3.26M | 9.91M | Net Debt |
-8.92M | -11.55M | -12.51M | -18.84M | -23.83M | -23.94M | Total Liabilities |
9.26M | 10.57M | 11.61M | 12.68M | 14.32M | 25.05M | Stockholders Equity |
31.37M | 32.63M | 35.87M | 44.11M | 51.50M | 52.69M |
Cash Flow | Free Cash Flow | ||||
-1.67M | -1.53M | -5.77M | -5.16M | -7.69M | -4.73M | Operating Cash Flow |
-1.25M | -1.10M | -4.39M | -2.29M | -6.34M | -3.37M | Investing Cash Flow |
-714.00K | -429.00K | -1.31M | -2.87M | -951.00K | 981.00K | Financing Cash Flow |
-50.00K | -307.00K | -160.00K | -1.46M | 528.00K | -5.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
60 Neutral | $14.12B | 6.43 | -3.57% | 3.69% | 2.49% | -35.43% | |
58 Neutral | $62.74M | ― | -34.39% | ― | 18.20% | 50.14% | |
55 Neutral | $73.32M | ― | -16.55% | ― | -2.67% | 21.65% | |
53 Neutral | $32.21M | 6.46 | 8.21% | ― | -8.74% | ― | |
46 Neutral | $34.98M | ― | -147.49% | ― | -4.46% | -3053.30% | |
45 Neutral | $96.60M | ― | -135.48% | ― | -12.77% | 19.71% | |
38 Underperform | $32.24M | ― | -123.16% | ― | -15.07% | 33.40% |
Marchex announced a new share repurchase program to buy back up to 3 million shares of its Class B common stock, replacing previous programs. The company reported its financial results for the first quarter of 2025, showing a slight decrease in revenue and an increased net loss compared to the previous year. Despite these results, Marchex is optimistic about future growth, highlighting strategic milestones in its transformation into an AI-powered prescriptive analytics leader. The company is expanding its product platform and increasing investments in sales and marketing to support growth, while leveraging its first-party data for enhanced customer insights. Marchex also sold a domain asset for $0.8 million and expanded its auto vertical OEM sales channel, expecting these initiatives to improve financial performance and market positioning.
The most recent analyst rating on (MCHX) stock is a Buy with a $2.50 price target. To see the full list of analyst forecasts on Marchex stock, see the MCHX Stock Forecast page.
Marchex has announced its financial results for the second quarter of 2023, highlighting a revenue increase driven by strong demand for its call analytics solutions. The company reported a net income improvement compared to the previous year, reflecting effective cost management and operational efficiencies. This financial performance underscores Marchex’s competitive positioning in the call analytics industry and suggests positive implications for its stakeholders.